ClinicalThought

Share

Program Content

Activities

  • Updates for HER2 CRC
    My Take on Tucatinib and Trastuzumab for HER2-Positive Metastatic Colorectal Cancer
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 10, 2022

    Expires: August 09, 2023

Provided by

ProCE Banner

Supporters

Bristol Myers Squibb

Seagen Inc.